case_images: PMC10616774_01
case_images: Biopsy findings. (A) Hematoxylin-eosin staining (x400); (B) Periodic-acid silver methenamine staining (x400); (C) Masson staining (x400); (D) Immunofluorescence staining for PLA2R (x400); (E) Immunohistochemical staining for THSD7A (x400); (F) Electron microscopy (x10000).
case_images: fimmu-14-1268929-g001.jpg
case_images: PMC10616774_01_fimmu-14-1268929-g001.jpg
case_images: f1
case_images: Pathological diagnosis was MN stages I-II ( Figure 1 ).
case_images: Overview of the treatment course. Cyclophosphamide (CYC), mycophenolate mofetil (MMF).
case_images: fimmu-14-1268929-g002.jpg
case_images: PMC10616774_01_fimmu-14-1268929-g002.jpg
case_images: f2
case_images: Urinary protein remained in a complete remission state, and prednisone was reduced to 25 mg qd on 12 August 2023 ( Figure 2 ).